机器学习驱动的脑脊液代谢组学评估:动脉瘤性蛛网膜下腔出血后不良结局的见解
该研究对81例动脉瘤性蛛网膜下腔出血(aSAH)患者的脑脊液样本进行液相色谱-串联质谱代谢组学分析,结合弹性网机器学习和正交偏最小二乘判别分析,发现对称二甲基精氨酸(SDMA)、二甲基胍戊酸(DMGV)和鸟氨酸与出院时及90天不良mRS独立相关,提示一氧化氮通路代谢物可预测不良结局。
要点
- SDMA、DMGV和鸟氨酸与aSAH后出院及90天不良mRS相关。
- SDMA在aSAH患者脑脊液中浓度显著高于非动脉瘤性SAH对照。
- 上述代谢物属一氧化氮通路血管活性分子,值得进一步研究。
核心结论
- SDMA、DMGV和鸟氨酸是与一氧化氮通路相关的血管活性分子,可预测重型aSAH后的不良结局。
研究设计与样本
- 回顾性队列生物样本库研究,纳入81例aSAH患者,采集迟发性脑缺血高峰期的脑脊液样本,采用液相色谱-串联质谱定量138种代谢物,并结合弹性网机器学习和正交偏最小二乘判别分析。
主要发现
- 弹性网机器学习和OPLS-DA分别识别出8种和10种可预测出院及90天不良mRS(mRS 3-6)的代谢物。
- SDMA、DMGV和鸟氨酸与出院时不良mRS相关(P值分别为.0005、.002和.0001),也与90天不良mRS相关(P值分别为.0036、.0001和.004)。
- SDMA在aSAH患者脑脊液中的浓度显著高于非动脉瘤性SAH对照(P=.0087)。
临床怎么用
- 脑脊液SDMA、DMGV和鸟氨酸或可作为aSAH后不良结局的候选生物标志物,但尚需进一步验证。
局限性
- 研究为回顾性队列设计,样本量有限(81例),代谢物预测价值需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aneurysmal subarachnoid hemorrhage (aSAH) is associated with a high mortality and poor neurologic outcomes. The biologic underpinnings of the morbidity and mortality associated with aSAH remain poorly understood. OBJECTIVE: To ascertain potential insights into pathological mechanisms of injury after aSAH using an approach of metabolomics coupled with machine learning methods. METHODS: Using cerebrospinal fluid (CSF) samples from 81 aSAH enrolled in a retrospective cohort biorepository, samples collected during the peak of delayed cerebral ischemia were analyzed using liquid chromatography-tandem mass spectrometry. A total of 138 metabolites were measured and quantified in each sample. Data were analyzed using elastic net (EN) machine learning and orthogonal partial least squares-discriminant analysis (OPLS-DA) to identify the leading CSF metabolites associated with poor outcome, as determined by the modified Rankin Scale (mRS) at discharge and at 90 d. Repeated measures analysis determined the effect size for each metabolite on poor outcome. RESULTS: EN machine learning and OPLS-DA analysis identified 8 and 10 metabolites, respectively, that predicted poor mRS (mRS 3-6) at discharge and at 90 d. Of these candidates, symmetric dimethylarginine (SDMA), dimethylguanidine valeric acid (DMGV), and ornithine were consistent markers, with an association with poor mRS at discharge (P = .0005, .002, and .0001, respectively) and at 90 d (P = .0036, .0001, and .004, respectively). SDMA also demonstrated a significantly elevated CSF concentration compared with nonaneurysmal subarachnoid hemorrhage controls (P = .0087). CONCLUSION: SDMA, DMGV, and ornithine are vasoactive molecules linked to the nitric oxide pathway that predicts poor outcome after severe aSAH. Further study of dimethylarginine metabolites in brain injury after aSAH is warranted.
引用
- Koch M, Acharjee A, Ament Z, et al. Machine Learning-Driven Metabolomic Evaluation of Cerebrospinal Fluid: Insights Into Poor Outcomes After Aneurysmal Subarachnoid Hemorrhage. Neurosurgery. 2021. PMID: 33469656. doi:10.1093/neuros/nyaa557
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。